1088 related articles for article (PubMed ID: 25517317)
1. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
2. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
[TBL] [Abstract][Full Text] [Related]
3. Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV.
Thueng-in K; Thanongsaksrikul J; Srimanote P; Bangphoomi K; Poungpair O; Maneewatch S; Choowongkomon K; Chaicumpa W
PLoS One; 2012; 7(11):e49254. PubMed ID: 23145135
[TBL] [Abstract][Full Text] [Related]
4. Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus.
Glab-Ampai K; Chulanetra M; Malik AA; Juntadech T; Thanongsaksrikul J; Srimanote P; Thueng-In K; Sookrung N; Tongtawe P; Chaicumpa W
Sci Rep; 2017 Nov; 7(1):15042. PubMed ID: 29118372
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
Nikonov A; Juronen E; Ustav M
J Biol Chem; 2008 Aug; 283(35):24089-102. PubMed ID: 18574240
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional characterization of the single-chain Fv fragment from a unique HCV E1E2-specific monoclonal antibody.
Fallecker C; Tarbouriech N; Habib M; Petit MA; Drouet E
FEBS Lett; 2013 Oct; 587(20):3335-40. PubMed ID: 24021643
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HCV replication by humanized-single domain transbodies to NS4B.
Glab-Ampai K; Malik AA; Chulanetra M; Thanongsaksrikul J; Thueng-In K; Srimanote P; Tongtawe P; Chaicumpa W
Biochem Biophys Res Commun; 2016 Aug; 476(4):654-664. PubMed ID: 27240954
[TBL] [Abstract][Full Text] [Related]
9. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
[TBL] [Abstract][Full Text] [Related]
10. Humanized-VHH transbodies that inhibit HCV protease and replication.
Jittavisutthikul S; Thanongsaksrikul J; Thueng-In K; Chulanetra M; Srimanote P; Seesuay W; Malik AA; Chaicumpa W
Viruses; 2015 Apr; 7(4):2030-56. PubMed ID: 25903832
[TBL] [Abstract][Full Text] [Related]
11. Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture.
Cheney IW; Naim S; Lai VC; Dempsey S; Bellows D; Walker MP; Shim JH; Horscroft N; Hong Z; Zhong W
Virology; 2002 Jun; 297(2):298-306. PubMed ID: 12083828
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
Lee KJ; Choi J; Ou JH; Lai MM
J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
[TBL] [Abstract][Full Text] [Related]
13. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
Manjula S; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
[TBL] [Abstract][Full Text] [Related]
14. [Screening and characterization of human phage antibody to hepatitis virus C NS5A antigen].
Cheng J; Zhong Y; Shi S; Liu Y; Wang G; Dong J; Xia XB; Chen JM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):216-8. PubMed ID: 11986687
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.
Wu JZ; Yao N; Walker M; Hong Z
Mini Rev Med Chem; 2005 Dec; 5(12):1103-12. PubMed ID: 16375756
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
[TBL] [Abstract][Full Text] [Related]
18. Human super antibody to viral RNA-dependent RNA polymerase produced by a modified Sortase self-cleave-bacteria surface display system.
Glab-Ampai K; Mahasongkram K; Chulanetra M; Saenlom T; Thueng-In K; Sookrung N; Chaicumpa W
Microb Cell Fact; 2023 Dec; 22(1):260. PubMed ID: 38110987
[TBL] [Abstract][Full Text] [Related]
19. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
[TBL] [Abstract][Full Text] [Related]
20. The C-terminal hydrophobic domain of hepatitis C virus RNA polymerase NS5B can be replaced with a heterologous domain of poliovirus protein 3A.
Lee H; Liu Y; Mejia E; Paul AV; Wimmer E
J Virol; 2006 Nov; 80(22):11343-54. PubMed ID: 16971430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
